Serra Veronica, Fattore Liana, Scherma Maria, Collu Roberto, Spano Maria Sabrina, Fratta Walter, Fadda Paola
Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cittadella Universitaria di Monserrato, 09042, Monserrato, CA, Italy.
Psychopharmacology (Berl). 2015 Jan;232(1):91-100. doi: 10.1007/s00213-014-3641-z. Epub 2014 Jun 13.
Salvinorin A is a recreational drug derived from Salvia divinorum, a sage species long used as an entheogen. While salvinorin A has potent hallucinogenic properties, its abuse potential has not been assessed consistently in controlled behavioural and neurochemical studies in rodents.
This study aimed to assess salvinorin A abuse potential by measuring its capacity to establish and maintain self-administration behaviour and to modify dopamine (DA) levels in the nucleus accumbens (NAcc) of rats.
Male Lister Hooded (LH) and Sprague-Dawley (SD) rats were allowed to self-administer salvinorin A (0.5 or 1.0 μg/kg/infusion) intravenously 2 h/day for 20 days under a continuous schedule of reinforcement and lever pressing as operandum. LH rats discriminated between the active and inactive levers but did not reach the acquisition criterion for stable self-administration (≥12 active responses vs ≤5 inactive responses for at least 5 consecutive days). SD rats discriminated between the two levers at the lower dose only but, like LH rats, never acquired stable self-administration behaviour. Systemic salvinorin A increased extracellular DA in the NAcc shell of both LH (at ≥40 μg/kg) and SD rats (at ≥5 μg/kg), but injection into the ventral tegmental area (VTA) induced no significant change in NAcc DA concentration in LH rats and only brief elevations in SD rats.
Salvinorin A differs from other commonly abused compounds since although it affects accumbal dopamine transmission, yet it is unable, at least at the tested doses, to sustain stable intravenous self-administration behaviour.
Salvinorin A是一种从鼠尾草属植物中提取的消遣性药物,该植物长期以来被用作致幻剂。虽然Salvinorin A具有强大的致幻特性,但在啮齿动物的对照行为和神经化学研究中,其滥用潜力尚未得到一致评估。
本研究旨在通过测量Salvinorin A建立和维持自我给药行为的能力以及改变大鼠伏隔核(NAcc)中多巴胺(DA)水平的能力,来评估其滥用潜力。
雄性利斯特戴帽大鼠(LH)和斯普拉格-道利大鼠(SD)在连续强化和以杠杆按压为操作条件的情况下,每天静脉注射Salvinorin A(0.5或1.0μg/kg/次输注)2小时,持续20天。LH大鼠能够区分活动杆和非活动杆,但未达到稳定自我给药的获取标准(至少连续5天,活动反应≥12次,非活动反应≤5次)。SD大鼠仅在较低剂量下能区分两根杠杆,但与LH大鼠一样,从未获得稳定的自我给药行为。全身性给予Salvinorin A会使LH大鼠(≥40μg/kg)和SD大鼠(≥5μg/kg)伏隔核壳中的细胞外多巴胺增加,但向腹侧被盖区(VTA)注射该药物,在LH大鼠中NAcc多巴胺浓度无显著变化,在SD大鼠中仅引起短暂升高。
Salvinorin A与其他常见的滥用化合物不同,因为尽管它会影响伏隔核多巴胺传递,但至少在所测试的剂量下,它无法维持稳定的静脉自我给药行为。